Diagnosis and management of polycystic liver disease

作者: Tom J. G. Gevers , Joost P. H. Drenth

DOI: 10.1038/NRGASTRO.2012.254

关键词:

摘要: Polycystic liver disease (PLD) is arbitrarily defined as a liver that contains> 20 cysts. The condition is associated with two genetically distinct diseases: as a primary phenotype in isolated polycystic liver disease (PCLD) and as an extrarenal manifestation in autosomal dominant polycystic kidney disease (ADPKD). Processes involved in hepatic cystogenesis include ductal plate malformation with concomitant abnormal fluid secretion, altered cell–matrix interaction and cholangiocyte hyperproliferation. PLD is usually a benign disease, but …

参考文章(93)
F. Temmerman, L. Missiaen, B. Bammens, W. Laleman, D. Cassiman, C. Verslype, J. van Pelt, F. Nevens, Systematic review: the pathophysiology and management of polycystic liver disease. Alimentary Pharmacology & Therapeutics. ,vol. 34, pp. 702- 713 ,(2011) , 10.1111/J.1365-2036.2011.04783.X
F.H.M. Corstens, W.J.G. Oyen, C.P. Bleeker-Rovers, F.J. Vos, Imaging of infectious diseases using [18F] fluorodeoxyglucose PET. Quarterly Journal of Nuclear Medicine and Molecular Imaging. ,vol. 52, pp. 17- 29 ,(2008)
Loes Van Keimpema, Daan B. De Koning, Bart Van Hoek, Aad P. Van Den Berg, Martijn G. H. Van Oijen, Robert A. De Man, Frederik Nevens, Joost P. H. Drenth, Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases. Liver International. ,vol. 31, pp. 92- 98 ,(2011) , 10.1111/J.1478-3231.2010.02247.X
Gabriele I. Kirchner, Kinan Rifai, Tobias Cantz, Bjoern Nashan, Christoph Terkamp, Thomas Becker, Christian Strassburg, Hannelore Barg-Hock, Siegfried Wagner, Rainer Lück, Juergen Klempnauer, Michael P. Manns, Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation Liver Transplantation. ,vol. 12, pp. 1268- 1277 ,(2006) , 10.1002/LT.20780
Sergio A. Gradilone, Tatyana V. Masyuk, Bing Q. Huang, Jesus M. Banales, Guillermo L. Lehmann, Brynn N. Radtke, Angela Stroope, Anatoliy I. Masyuk, Patrick L. Splinter, Nicholas F. LaRusso, Activation of Trpv4 Reduces the Hyperproliferative Phenotype of Cystic Cholangiocytes From an Animal Model of ARPKD Gastroenterology. ,vol. 139, pp. 304- 314 ,(2010) , 10.1053/J.GASTRO.2010.04.010
Tom JG Gevers, Joost PH Drenth, Somatostatin analogues for treatment of polycystic liver disease. Current Opinion in Gastroenterology. ,vol. 27, pp. 294- 300 ,(2011) , 10.1097/MOG.0B013E328343433F
R Sherstha, C McKinley, P Russ, A Scherzinger, T Bronner, R Showalter, G T Everson, Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology. ,vol. 26, pp. 1282- 1286 ,(1997) , 10.1002/HEP.510260528
Caroline Robinson, Thomas F Hiemstra, Deborah Spencer, Sarah Waller, Laura Daboo, Fiona E Karet Frankl, Richard N Sandford, Clinical utility of PKD2 mutation testing in a polycystic kidney disease cohort attending a specialist nephrology out-patient clinic. BMC Nephrology. ,vol. 13, pp. 79- 79 ,(2012) , 10.1186/1471-2369-13-79
Carlo Spirli, Luigi Locatelli, Romina Fiorotto, Carola M. Morell, Luca Fabris, Tullio Pozzan, Mario Strazzabosco, Altered store operated calcium entry increases cyclic 3',5'-adenosine monophosphate production and extracellular signal-regulated kinases 1 and 2 phosphorylation in polycystin-2-defective cholangiocytes. Hepatology. ,vol. 55, pp. 856- 868 ,(2012) , 10.1002/HEP.24723